WASHINGTON -- Six members of the House of Representatives have called on the Government Accountability Office (GAO) to investigate whether contracting practices by hospital purchasing organizations are an underlying cause of ongoing shortages of generic drugs.
Specifically, the six want to know whether group purchasing organizations (GPOs) have designed exclusive contracts for drugs and devices that have had detrimental effects on generic drugmakers -- potentially leading to drug shortages and an increased reliance on compounding pharmacies.
Continue Reading here
No comments:
Post a Comment